| abstract |
There are provided a non-human primate ORL1 gene etc., using a nucleic acid having the nucleotide sequence listed as SEQ ID NO: 1, a protein having the amino acid sequence listed as SEQ ID NO: 2, a recombinant vector containing a gene consisting of the nucleic acid, and a transformant cell containing the recombinant vector, whereby it is possible to evaluate and screen for compounds that act on ORL1. |